» Articles » PMID: 25803104

Wilson's Disease: a Comprehensive Review of the Molecular Mechanisms

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2015 Mar 25
PMID 25803104
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

Wilson's disease (WD), also known as hepatolenticular degeneration, is an autosomal recessive inherited disorder resulting from abnormal copper metabolism. Reduced copper excretion causes an excessive deposition of the copper in many organs such as the liver, central nervous system (CNS), cornea, kidney, joints, and cardiac muscle where the physiological functions of the affected organs are impaired. The underlying molecular mechanisms for WD have been extensively studied. It is now believed that a defect in P-type adenosine triphosphatase (ATP7B), the gene encoding the copper transporting P-type ATPase, is responsible for hepatic copper accumulation. Deposited copper in the liver produces toxic effects via modulating several molecular pathways. WD can be a lethal disease if left untreated. A better understanding of the molecular mechanisms causing the aberrant copper deposition and organ damage is the key to developing effective management approaches.

Citing Articles

Post-transplant liver biopsies: a concise and practical approach for beginners.

Ourfali M, Hirsch D, Scranton M, Jabbour T J Pathol Transl Med. 2025; 59(1):1-10.

PMID: 39815741 PMC: 11736277. DOI: 10.4132/jptm.2024.11.15.


Psychiatric Symptoms in Wilson's Disease-Consequence of Gene Mutations or Just Coincidence?-Possible Causal Cascades and Molecular Pathways.

Gromadzka G, Antos A, Sorysz Z, Litwin T Int J Mol Sci. 2024; 25(22).

PMID: 39596417 PMC: 11595239. DOI: 10.3390/ijms252212354.


Effect of primary copper metabolism disturbance on elemental, protein, and lipid composition of the organs in Jackson toxic milk mouse.

Hadrian K, Szczerbowska-Boruchowska M, Surowka A, Ciepiela O, Litwin T, Przybylkowski A Biometals. 2024; 38(1):103-121.

PMID: 39365499 PMC: 11754380. DOI: 10.1007/s10534-024-00640-y.


Wilson's Disease-Crossroads of Genetics, Inflammation and Immunity/Autoimmunity: Clinical and Molecular Issues.

Gromadzka G, Czerwinska J, Krzeminska E, Przybylkowski A, Litwin T Int J Mol Sci. 2024; 25(16).

PMID: 39201720 PMC: 11354778. DOI: 10.3390/ijms25169034.


Osteochondral lesions in Wilson's disease: case report and literature review.

Valmadrid L, Lystad H, Smitaman E, Vitale K AME Case Rep. 2024; 8:80.

PMID: 39091553 PMC: 11292064. DOI: 10.21037/acr-23-217.


References
1.
Roberts E, Robinson B, Yang S . Mitochondrial structure and function in the untreated Jackson toxic milk (tx-j) mouse, a model for Wilson disease. Mol Genet Metab. 2007; 93(1):54-65. DOI: 10.1016/j.ymgme.2007.08.127. View

2.
Gouider-Khouja N . Wilson's disease. Parkinsonism Relat Disord. 2010; 15 Suppl 3:S126-9. DOI: 10.1016/S1353-8020(09)70798-9. View

3.
Fatemi N, Sarkar B . Molecular mechanism of copper transport in Wilson disease. Environ Health Perspect. 2002; 110 Suppl 5:695-8. PMC: 1241227. DOI: 10.1289/ehp.02110s5695. View

4.
Ala A, Borjigin J, Rochwarger A, Schilsky M . Wilson disease in septuagenarian siblings: Raising the bar for diagnosis. Hepatology. 2005; 41(3):668-70. DOI: 10.1002/hep.20601. View

5.
Kucinskas L, Jeroch J, Vitkauskiene A, Sakalauskas R, Petrenkiene V, Kucinskas V . High frequency of the c.3207C>A (p.H1069Q) mutation in ATP7B gene of Lithuanian patients with hepatic presentation of Wilson's disease. World J Gastroenterol. 2008; 14(38):5876-9. PMC: 2751898. DOI: 10.3748/wjg.14.5876. View